Production of high-quality carbon fibre components at the core of the business PORTO, Portugal, March 13, 2024 /PRNewswire/ — From its facilities in Perafita, on the outskirts of Porto, Adamastor is currently working on the development of the first Portuguese supercar. But the highly specialised team working in the areas of engineering, production and design also… Continue reading Adamastor is the premium engineering centre where the first Portuguese supercar is being developed
Category: Newswire
Teleste strengthens information display portfolio through partnership with Papercast
TURKU, Finland, March 13, 2024 /PRNewswire/ — Teleste is delighted to announce a significant expansion of its information display offering through collaboration with Papercast®, the world’s leader in battery and solar powered e-paper signage displays. Commencing from March 2024, Teleste will be offering the Papercast e-paper displays to its public transport clientele on a global… Continue reading Teleste strengthens information display portfolio through partnership with Papercast
Global Times: Xi puts new quality productive forces at front and center in China’s economic agenda
BEIJING, March 15, 2024 /PRNewswire/ — This year’s two sessions – China’s annual legislative and political consultative sessions – officially concluded on Monday, after national lawmakers and political advisers spent a week or so, on mapping the country’s social and economic development blueprint for 2024 and beyond. Often described as one of the most important… Continue reading Global Times: Xi puts new quality productive forces at front and center in China’s economic agenda
European Wellness et le gouvernement de Sabah vont faire de l’État un centre de biotechnologie de classe mondiale pour le tourisme médical et de bien-être
KOTA KINABALU, Malaisie, 15 mars 2024 /PRNewswire/ — European Wellness, leader dans le domaine de la santé et du bien-être, annonce une collaboration inédite avec le gouvernement de l’État de Sabah, visant à faire de cet État une destination de choix pour le tourisme médical et de bien-être à l’échelle mondiale. Le ministre en chef Datuk Seri Hajiji Noor salue… Continue reading European Wellness et le gouvernement de Sabah vont faire de l’État un centre de biotechnologie de classe mondiale pour le tourisme médical et de bien-être
Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
JINAN, China, March 15, 2024 /PRNewswire/ — On 8 March local time, during the 25th European Society of Gynecological Oncology (ESGO) Conference (ESGO 2024) in Spain, Qilu Pharmaceutical unveiled the Phase II clinical trial results for iparomlimab and tuvonralimab (QL1706) in an oral presentation. This trial, known as DUBHE-C-206, recruited patients with recurrent or metastatic… Continue reading Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
Personal Consumer Electronics Market size to grow by USD 92.66 billion from 2022 to 2027, Frequent product launches boost the market, Technavio
NEW YORK, March 15, 2024 /PRNewswire/ — The personal consumer electronics market size is forecast to increase by USD 92.66 billion from 2022 to 2027. The market is estimated to grow at a CAGR of 5.04%, according to a recent market study by Technavio. In a thriving global market, vendors are driving growth through frequent product launches and a relentless… Continue reading Personal Consumer Electronics Market size to grow by USD 92.66 billion from 2022 to 2027, Frequent product launches boost the market, Technavio
Industrial Chain Drives Market size to increase by USD 824.75 million during 2022 to 2027, Growing end-user investments in APAC boosts the market growth, Technavio
NEW YORK, March 15, 2024 /PRNewswire/ — The industrial chain drives market is expected to grow by USD 824.75 million between 2022 and 2027. However, the growth momentum of the market will progress at a CAGR of 3.59% during the forecast period. The increasing end-user investments in the APAC region serve as a pivotal catalyst propelling market… Continue reading Industrial Chain Drives Market size to increase by USD 824.75 million during 2022 to 2027, Growing end-user investments in APAC boosts the market growth, Technavio
ROHM Develops Automotive Primary LDOs: Leveraging Original QuiCur(TM) Technology to Achieve Industry-Leading Load Response Characteristics
-Ensuring Stable Output in Automotive Applications with High Input Voltage and Significant Load Jumps- KYOTO, Japan, March 15, 2024 /PRNewswire/ — ROHM Co., Ltd. has developed 45V-rated 500mA-output primary LDO regulators: BD9xxM5-C. These devices are suitable for supplying power to automotive electronic components such as ECUs that operate from vehicle batteries. BD9xxM5-C: https://www.rohm.com/products/power-management/linear-regulators/single-output-ldo-regulators?page=1&PS_ProductSeries=BD9xxM5%20series&PS_CommonStandard=AEC-Q100%20(Automotive%20Grade)#parametricSearch Logo: https://cdn.kyodonewsprwire.jp/prwfile/release/M106254/202403087752/_prw_PI4fl_KmMw5Jg7.jpg … Continue reading ROHM Develops Automotive Primary LDOs: Leveraging Original QuiCur(TM) Technology to Achieve Industry-Leading Load Response Characteristics
Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
JINAN, China, March 15, 2024 /PRNewswire/ — On 8 March local time, during the 25th European Society of Gynecological Oncology (ESGO) Conference (ESGO 2024) in Spain, Qilu Pharmaceutical unveiled the Phase II clinical trial results for iparomlimab and tuvonralimab (QL1706) in an oral presentation. This trial, known as DUBHE-C-206, recruited patients with recurrent or metastatic… Continue reading Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
ImmVira’s oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment
SHENZHEN, China, March 15, 2024 /PRNewswire/ — ImmVira has recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for oncolytic virus product MVR-T3011 IT (intratumoral injection) for the treatment of recurrent or metastatic head and neck squamous cell cancer with disease progression after platinum-based chemotherapy and at least one prior… Continue reading ImmVira’s oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment